+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Line and Membrane Market By Products, By Source, By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 346 Pages
  • September 2022
  • Region: Global
  • Allied Market Research
  • ID: 5713211
The global cell line and membrane market was valued at $4,533.04 million in 2021, and is projected to reach $10,574.56 million by 2031, registering a CAGR of 8.8% from 2022 to 2031.A cell line is a permanently established cell culture that will multiply indefinitely in a given appropriate fresh medium and space and is frequently used to investigate biological processes in place of primary cells. Transfection, selection, and single-cell cloning are all a part of the cell line generation process. Various types of cells are used to create different cell lines. Cell lines allow for the gradual changes in cell structure, physiology, and genetic makeup in a controlled setting.. Cell lines are derived from single cells and are used to make fusion proteins, monoclonal antibodies, and vaccines.

Cell lines have revolutionized scientific research and they are widely used in the production of vaccine, testing drug metabolism & cytotoxicity, antibody production, study of gene function, generation of artificial tissues (artificial skin), and synthesis of biological compounds (therapeutic proteins).

The key factors that drive the growth of market are rise in the prevalence of cancer & chronic diseases, rise in geriatric population, and increase in number of vaccine production. In addition, the rise in novel drug development activities, growth in use of mammalian cell for cell line production, and surge in technological advancements in expression vector design are the key factors that boost the market growth. For instance, according to the International Agency of Cancer Research, 9,503,710 new cancer cases were diagnosed in Asia in 2020.

However, the strict regulatory framework coupled with the time-consuming process for the development of stable lines hampers the market growth. Conversely, emerging healthcare market in developing countries & low-income countries and increase in the risk of pandemic & communicable diseases are expected to provide lucrative opportunity for the growth of market during the forecast period.

The cell line and membrane market is segmented on the basis of product, source, type, end user, and region. By product, the market is fragmented into media & reagents, equipment, accessories, and consumables. By source, it is bifurcated into mammalian cell line and non-mammalian cell line. On the basis of type, the market is categorized into recombinant cell type, hybridomas, continuous cell line and primary cell line. By end user, the market is divided into biotech companies, academic and research institutes and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the cell line and membrane market share in 2021 and is anticipated to remain dominant during the forecast period owing to rise in the prevalence of cancer, increased use of media & reagents for cell line development, and presence of major key players in the region.

Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in prevalence of chronic diseases and increase in geriatric population in developing countries.

The key players that operate in the cell line and membrane market are Advanced Instruments LLC, AGC Biologics, Cytiva Lifesciences, Sartorius Cellgenix Gmbh, Premas Biotech, Selexis SA, Lonza, Samsung Biologics, PromoCell, Thermofisher Scientific Inc, Imegenex India Pvt. Ltd., and ProBioGen.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell line and membrane market analysis from 2021 to 2031 to identify the prevailing cell line and membrane market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cell line and membrane market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cell line and membrane market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Products

  • Media and Reagents
  • Type
  • Serum
  • Media
  • Reagents
  • Equipments
  • Type
  • Biosafety Cabinets
  • Cell Counters and Viability Systems
  • Incubators
  • Centrifuges
  • Bioreactors
  • Storage Equipment
  • Others
  • Accessories and Consumables

By Source

  • Non Mammalian Cell Line
  • Type
  • Insects
  • Amphibians
  • Mammalian Cell Line

By Type

  • Hybridomas
  • Continuous cell lines
  • Recombinant cell lines
  • Primary cell lines

By End User

  • Biotechnology and Pharmaceutical Industries
  • Academic and Research Institutes
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest Of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest Of LAMEA

Key Market Players

  • Advanced Instruments LLC
  • AGC Biologics
  • Cytiva Lifesciences
  • Sartorius
  • Cellgenix Gmbh
  • Premas Biotech
  • Selexis SA
  • Samsung Biologics
  • Lonza
  • Thermofisher Scientific Inc
  • PromoCell
  • ProBioGen
Frequently Asked Questions about the Global Cell Line and Membrane Market

What is the estimated value of the Global Cell Line and Membrane Market?

The Global Cell Line and Membrane Market was estimated to be valued at $4533.04 million in 2021.

What is the growth rate of the Global Cell Line and Membrane Market?

The growth rate of the Global Cell Line and Membrane Market is 8.8%, with an estimated value of $10574.56 million by 2031.

What is the forecasted size of the Global Cell Line and Membrane Market?

The Global Cell Line and Membrane Market is estimated to be worth $10574.56 million by 2031.

Who are the key companies in the Global Cell Line and Membrane Market?

Key companies in the Global Cell Line and Membrane Market include Advanced Instruments LLC, AGC Biologics, Cytiva Lifesciences, Sartorius, Cellgenix Gmbh, Premas Biotech, Selexis SA, Samsung Biologics and Thermofisher Scientific Inc.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: CELL LINE AND MEMBRANE MARKET, BY PRODUCTS
4.1 Overview
4.1.1 Market size and forecast
4.2 Media and Reagents
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Media and Reagents Cell Line and Membrane Market by Type
4.2.4.1 Serum Market size and forecast, by region
4.2.4.2 Media Market size and forecast, by region
4.2.4.3 Reagents Market size and forecast, by region
4.3 Equipments
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Equipments Cell Line and Membrane Market by Type
4.3.4.1 Biosafety Cabinets Market size and forecast, by region
4.3.4.2 Cell Counters and Viability Systems Market size and forecast, by region
4.3.4.3 Incubators Market size and forecast, by region
4.3.4.4 Centrifuges Market size and forecast, by region
4.3.4.5 Bioreactors Market size and forecast, by region
4.3.4.6 Storage Equipment Market size and forecast, by region
4.3.4.7 Others Market size and forecast, by region
4.4 Accessories and Consumables
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country

CHAPTER 5: CELL LINE AND MEMBRANE MARKET, BY SOURCE
5.1 Overview
5.1.1 Market size and forecast
5.2 Non Mammalian Cell Line
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Non Mammalian Cell Line Cell Line and Membrane Market by Type
5.2.4.1 Insects Market size and forecast, by region
5.2.4.2 Amphibians Market size and forecast, by region
5.3 Mammalian Cell Line
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country

CHAPTER 6: CELL LINE AND MEMBRANE MARKET, BY TYPE
6.1 Overview
6.1.1 Market size and forecast
6.2 Recombinant cell lines
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Primary cell lines
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Hybridomas
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Continuous cell lines
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country

CHAPTER 7: CELL LINE AND MEMBRANE MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Biotechnology and Pharmaceutical Industries
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Academic and Research Institutes
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Others
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country

CHAPTER 8: CELL LINE AND MEMBRANE MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Products
8.2.2.1 North America Media and Reagents Cell Line and Membrane Market by Type
8.2.2.2 North America Equipments Cell Line and Membrane Market by Type
8.2.3 North America Market size and forecast, by Source
8.2.3.1 North America Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.2.4 North America Market size and forecast, by Type
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Products
8.2.6.1.2 Market size and forecast, by Source
8.2.6.1.3 Market size and forecast, by Type
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Products
8.2.6.2.2 Market size and forecast, by Source
8.2.6.2.3 Market size and forecast, by Type
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Products
8.2.6.3.2 Market size and forecast, by Source
8.2.6.3.3 Market size and forecast, by Type
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Products
8.3.2.1 Europe Media and Reagents Cell Line and Membrane Market by Type
8.3.2.2 Europe Equipments Cell Line and Membrane Market by Type
8.3.3 Europe Market size and forecast, by Source
8.3.3.1 Europe Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.3.4 Europe Market size and forecast, by Type
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Products
8.3.6.1.2 Market size and forecast, by Source
8.3.6.1.3 Market size and forecast, by Type
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Products
8.3.6.2.2 Market size and forecast, by Source
8.3.6.2.3 Market size and forecast, by Type
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Market size and forecast, by Products
8.3.6.3.2 Market size and forecast, by Source
8.3.6.3.3 Market size and forecast, by Type
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Products
8.3.6.4.2 Market size and forecast, by Source
8.3.6.4.3 Market size and forecast, by Type
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Products
8.3.6.5.2 Market size and forecast, by Source
8.3.6.5.3 Market size and forecast, by Type
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Products
8.3.6.6.2 Market size and forecast, by Source
8.3.6.6.3 Market size and forecast, by Type
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Products
8.4.2.1 Asia-Pacific Media and Reagents Cell Line and Membrane Market by Type
8.4.2.2 Asia-Pacific Equipments Cell Line and Membrane Market by Type
8.4.3 Asia-Pacific Market size and forecast, by Source
8.4.3.1 Asia-Pacific Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.4.4 Asia-Pacific Market size and forecast, by Type
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Products
8.4.6.1.2 Market size and forecast, by Source
8.4.6.1.3 Market size and forecast, by Type
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Products
8.4.6.2.2 Market size and forecast, by Source
8.4.6.2.3 Market size and forecast, by Type
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Products
8.4.6.3.2 Market size and forecast, by Source
8.4.6.3.3 Market size and forecast, by Type
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Products
8.4.6.4.2 Market size and forecast, by Source
8.4.6.4.3 Market size and forecast, by Type
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Products
8.4.6.5.2 Market size and forecast, by Source
8.4.6.5.3 Market size and forecast, by Type
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Products
8.4.6.6.2 Market size and forecast, by Source
8.4.6.6.3 Market size and forecast, by Type
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Products
8.5.2.1 LAMEA Media and Reagents Cell Line and Membrane Market by Type
8.5.2.2 LAMEA Equipments Cell Line and Membrane Market by Type
8.5.3 LAMEA Market size and forecast, by Source
8.5.3.1 LAMEA Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.5.4 LAMEA Market size and forecast, by Type
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Products
8.5.6.1.2 Market size and forecast, by Source
8.5.6.1.3 Market size and forecast, by Type
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Products
8.5.6.2.2 Market size and forecast, by Source
8.5.6.2.3 Market size and forecast, by Type
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Products
8.5.6.3.2 Market size and forecast, by Source
8.5.6.3.3 Market size and forecast, by Type
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Products
8.5.6.4.2 Market size and forecast, by Source
8.5.6.4.3 Market size and forecast, by Type
8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES
10.1 Advanced Instruments LLC
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 AGC Biologics
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Cytiva Lifesciences
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Sartorius
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Cellgenix Gmbh
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Premas Biotech
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Selexis SA
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Samsung Biologics
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Lonza
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Thermofisher Scientific Inc
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 PromoCell
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 ProBioGen
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments

List of Tables
Table 1. Global Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 2. Cell Line and Membrane Market, for Media and Reagents, by Region, 2021-2031 ($Million)
Table 3. Cell Line and Membrane Market for Media and Reagents, by Country, 2021-2031 ($Million)
Table 4. Global Media and Reagents Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 5. Cell Line and Membrane Market, for Serum, by Region, 2021-2031 ($Million)
Table 6. Cell Line and Membrane Market, for Media, by Region, 2021-2031 ($Million)
Table 7. Cell Line and Membrane Market, for Reagents, by Region, 2021-2031 ($Million)
Table 8. Cell Line and Membrane Market, for Equipments, by Region, 2021-2031 ($Million)
Table 9. Cell Line and Membrane Market for Equipments, by Country, 2021-2031 ($Million)
Table 10. Global Equipments Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 11. Cell Line and Membrane Market, for Biosafety Cabinets, by Region, 2021-2031 ($Million)
Table 12. Cell Line and Membrane Market, for Cell Counters and Viability Systems, by Region, 2021-2031 ($Million)
Table 13. Cell Line and Membrane Market, for Incubators, by Region, 2021-2031 ($Million)
Table 14. Cell Line and Membrane Market, for Centrifuges, by Region, 2021-2031 ($Million)
Table 15. Cell Line and Membrane Market, for Bioreactors, by Region, 2021-2031 ($Million)
Table 16. Cell Line and Membrane Market, for Storage Equipment, by Region, 2021-2031 ($Million)
Table 17. Cell Line and Membrane Market, for Others, by Region, 2021-2031 ($Million)
Table 18. Cell Line and Membrane Market, for Accessories and Consumables, by Region, 2021-2031 ($Million)
Table 19. Cell Line and Membrane Market for Accessories and Consumables, by Country, 2021-2031 ($Million)
Table 20. Global Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 21. Cell Line and Membrane Market, for Non Mammalian Cell Line, by Region, 2021-2031 ($Million)
Table 22. Cell Line and Membrane Market for Non Mammalian Cell Line, by Country, 2021-2031 ($Million)
Table 23. Global Non Mammalian Cell Line Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 24. Cell Line and Membrane Market, for Insects, by Region, 2021-2031 ($Million)
Table 25. Cell Line and Membrane Market, for Amphibians, by Region, 2021-2031 ($Million)
Table 26. Cell Line and Membrane Market, for Mammalian Cell Line, by Region, 2021-2031 ($Million)
Table 27. Cell Line and Membrane Market for Mammalian Cell Line, by Country, 2021-2031 ($Million)
Table 28. Global Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 29. Cell Line and Membrane Market, for Recombinant Cell Lines, by Region, 2021-2031 ($Million)
Table 30. Cell Line and Membrane Market for Recombinant Cell Lines, by Country, 2021-2031 ($Million)
Table 31. Cell Line and Membrane Market, for Primary Cell Lines, by Region, 2021-2031 ($Million)
Table 32. Cell Line and Membrane Market for Primary Cell Lines, by Country, 2021-2031 ($Million)
Table 33. Cell Line and Membrane Market, for Hybridomas, by Region, 2021-2031 ($Million)
Table 34. Cell Line and Membrane Market for Hybridomas, by Country, 2021-2031 ($Million)
Table 35. Cell Line and Membrane Market, for Continuous Cell Lines, by Region, 2021-2031 ($Million)
Table 36. Cell Line and Membrane Market for Continuous Cell Lines, by Country, 2021-2031 ($Million)
Table 37. Global Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 38. Cell Line and Membrane Market, for Biotechnology and Pharmaceutical Industries, by Region, 2021-2031 ($Million)
Table 39. Cell Line and Membrane Market for Biotechnology and Pharmaceutical Industries, by Country, 2021-2031 ($Million)
Table 40. Cell Line and Membrane Market, for Academic and Research Institutes, by Region, 2021-2031 ($Million)
Table 41. Cell Line and Membrane Market for Academic and Research Institutes, by Country, 2021-2031 ($Million)
Table 42. Cell Line and Membrane Market, for Others, by Region, 2021-2031 ($Million)
Table 43. Cell Line and Membrane Market for Others, by Country, 2021-2031 ($Million)
Table 44. Cell Line and Membrane Market, by Region, 2021-2031 ($Million)
Table 45. North America Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 46. North America Media and Reagents Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 47. North America Equipments Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 48. North America Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 49. North America Non Mammalian Cell Line Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 50. North America Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 51. North America Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 52. North America Cell Line and Membrane Market, by Country, 2021-2031 ($Million)
Table 53. U.S. Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 54. U.S. Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 55. U.S. Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 56. U.S. Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 57. Canada Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 58. Canada Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 59. Canada Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 60. Canada Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 61. Mexico Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 62. Mexico Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 63. Mexico Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 64. Mexico Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 65. Europe Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 66. Europe Media and Reagents Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 67. Europe Equipments Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 68. Europe Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 69. Europe Non Mammalian Cell Line Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 70. Europe Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 71. Europe Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 72. Europe Cell Line and Membrane Market, by Country, 2021-2031 ($Million)
Table 73. Germany Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 74. Germany Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 75. Germany Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 76. Germany Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 77. France Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 78. France Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 79. France Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 80. France Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 81. UK Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 82. UK Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 83. UK Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 84. UK Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 85. Italy Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 86. Italy Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 87. Italy Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 88. Italy Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 89. Spain Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 90. Spain Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 91. Spain Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 92. Spain Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 93. Rest of Europe Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 94. Rest of Europe Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 95. Rest of Europe Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 96. Rest of Europe Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 97. Asia-Pacific Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 98. Asia-Pacific Media and Reagents Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 99. Asia-Pacific Equipments Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 100. Asia-Pacific Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 101. Asia-Pacific Non Mammalian Cell Line Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 102. Asia-Pacific Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 103. Asia-Pacific Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 104. Asia-Pacific Cell Line and Membrane Market, by Country, 2021-2031 ($Million)
Table 105. Japan Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 106. Japan Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 107. Japan Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 108. Japan Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 109. China Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 110. China Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 111. China Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 112. China Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 113. Australia Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 114. Australia Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 115. Australia Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 116. Australia Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 117. India Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 118. India Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 119. India Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 120. India Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 121. South Korea Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 122. South Korea Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 123. South Korea Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 124. South Korea Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 125. Rest of Asia-Pacific Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 126. Rest of Asia-Pacific Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 127. Rest of Asia-Pacific Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 128. Rest of Asia-Pacific Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 129. LAMEA Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 130. LAMEA Media and Reagents Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 131. LAMEA Equipments Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 132. LAMEA Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 133. LAMEA Non Mammalian Cell Line Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 134. LAMEA Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 135. LAMEA Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 136. LAMEA Cell Line and Membrane Market, by Country, 2021-2031 ($Million)
Table 137. Brazil Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 138. Brazil Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 139. Brazil Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 140. Brazil Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 141. Saudi Arabia Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 142. Saudi Arabia Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 143. Saudi Arabia Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 144. Saudi Arabia Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 145. South Africa Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 146. South Africa Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 147. South Africa Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 148. South Africa Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 149. Rest of LAMEA Cell Line and Membrane Market, by Products, 2021-2031 ($Million)
Table 150. Rest of LAMEA Cell Line and Membrane Market, by Source, 2021-2031 ($Million)
Table 151. Rest of LAMEA Cell Line and Membrane Market, by Type, 2021-2031 ($Million)
Table 152. Rest of LAMEA Cell Line and Membrane Market, by End-user, 2021-2031 ($Million)
Table 153. Advanced Instruments LLC: Company Snapshot
Table 154. Advanced Instruments LLC: Operating Segments
Table 155. Advanced Instruments LLC: Product Portfolio
Table 156. Advanced Instruments LLC: Net Sales
Table 157. Advanced Instruments LLC: Key Strategies
Table 158. Agc Biologics: Company Snapshot
Table 159. Agc Biologics: Operating Segments
Table 160. Agc Biologics: Product Portfolio
Table 161. Agc Biologics: Net Sales
Table 162. Agc Biologics: Key Strategies
Table 163. Cytiva Lifesciences: Company Snapshot
Table 164. Cytiva Lifesciences: Operating Segments
Table 165. Cytiva Lifesciences: Product Portfolio
Table 166. Cytiva Lifesciences: Net Sales
Table 167. Cytiva Lifesciences: Key Strategies
Table 168. Sartorius: Company Snapshot
Table 169. Sartorius: Operating Segments
Table 170. Sartorius: Product Portfolio
Table 171. Sartorius: Net Sales
Table 172. Sartorius: Key Strategies
Table 173. Cellgenix GmbH: Company Snapshot
Table 174. Cellgenix GmbH: Operating Segments
Table 175. Cellgenix GmbH: Product Portfolio
Table 176. Cellgenix GmbH: Net Sales
Table 177. Cellgenix GmbH: Key Strategies
Table 178. Premas Biotech: Company Snapshot
Table 179. Premas Biotech: Operating Segments
Table 180. Premas Biotech: Product Portfolio
Table 181. Premas Biotech: Net Sales
Table 182. Premas Biotech: Key Strategies
Table 183. Selexis SA: Company Snapshot
Table 184. Selexis SA: Operating Segments
Table 185. Selexis SA: Product Portfolio
Table 186. Selexis SA: Net Sales
Table 187. Selexis SA: Key Strategies
Table 188. Samsung Biologics: Company Snapshot
Table 189. Samsung Biologics: Operating Segments
Table 190. Samsung Biologics: Product Portfolio
Table 191. Samsung Biologics: Net Sales
Table 192. Samsung Biologics: Key Strategies
Table 193. Lonza: Company Snapshot
Table 194. Lonza: Operating Segments
Table 195. Lonza: Product Portfolio
Table 196. Lonza: Net Sales
Table 197. Lonza: Key Strategies
Table 198. Thermofisher Scientific Inc.: Company Snapshot
Table 199. Thermofisher Scientific Inc.: Operating Segments
Table 200. Thermofisher Scientific Inc.: Product Portfolio
Table 201. Thermofisher Scientific Inc.: Net Sales
Table 202. Thermofisher Scientific Inc.: Key Strategies
Table 203. Promocell: Company Snapshot
Table 204. Promocell: Operating Segments
Table 205. Promocell: Product Portfolio
Table 206. Promocell: Net Sales
Table 207. Promocell: Key Strategies
Table 208. Probiogen: Company Snapshot
Table 209. Probiogen: Operating Segments
Table 210. Probiogen: Product Portfolio
Table 211. Probiogen: Net Sales
Table 212. Probiogen: Key Strategies

List of Figures
Figure 1. Cell Line and Membrane Market Segmentation
Figure 2. Cell Line and Membrane Market, 2021-2031
Figure 3. Cell Line and Membrane Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Cell Line and Membrane Mark.:Drivers, Restraints and Opportunities
Figure 12. Cell Line and Membrane Market, By Products, 2021(%)
Figure 13. Comparative Share Analysis of Media and Reagents Cell Line and Membrane Market, 2021-2031(%)
Figure 14. Comparative Share Analysis of Equipments Cell Line and Membrane Market, 2021-2031(%)
Figure 15. Comparative Share Analysis of Accessories and Consumables Cell Line and Membrane Market, 2021-2031(%)
Figure 16. Cell Line and Membrane Market, By Source, 2021(%)
Figure 17. Comparative Share Analysis of Non Mammalian Cell Line Cell Line and Membrane Market, 2021-2031(%)
Figure 18. Comparative Share Analysis of Mammalian Cell Line Cell Line and Membrane Market, 2021-2031(%)
Figure 19. Cell Line and Membrane Market, By Type, 2021(%)
Figure 20. Comparative Share Analysis of Recombinant Cell Lines Cell Line and Membrane Market, 2021-2031(%)
Figure 21. Comparative Share Analysis of Primary Cell Lines Cell Line and Membrane Market, 2021-2031(%)
Figure 22. Comparative Share Analysis of Hybridomas Cell Line and Membrane Market, 2021-2031(%)
Figure 23. Comparative Share Analysis of Continuous Cell Lines Cell Line and Membrane Market, 2021-2031(%)
Figure 24. Cell Line and Membrane Market, By End-user, 2021(%)
Figure 25. Comparative Share Analysis of Biotechnology and Pharmaceutical Industries Cell Line and Membrane Market, 2021-2031(%)
Figure 26. Comparative Share Analysis of Academic and Research Institutes Cell Line and Membrane Market, 2021-2031(%)
Figure 27. Comparative Share Analysis of Others Cell Line and Membrane Market, 2021-2031(%)
Figure 28. Cell Line and Membrane Market by Region, 2021
Figure 29. U.S. Cell Line and Membrane Market, 2021-2031($Million)
Figure 30. Canada Cell Line and Membrane Market, 2021-2031($Million)
Figure 31. Mexico Cell Line and Membrane Market, 2021-2031($Million)
Figure 32. Germany Cell Line and Membrane Market, 2021-2031($Million)
Figure 33. France Cell Line and Membrane Market, 2021-2031($Million)
Figure 34. Uk Cell Line and Membrane Market, 2021-2031($Million)
Figure 35. Italy Cell Line and Membrane Market, 2021-2031($Million)
Figure 36. Spain Cell Line and Membrane Market, 2021-2031($Million)
Figure 37. Rest of Europe Cell Line and Membrane Market, 2021-2031($Million)
Figure 38. Japan Cell Line and Membrane Market, 2021-2031($Million)
Figure 39. China Cell Line and Membrane Market, 2021-2031($Million)
Figure 40. Australia Cell Line and Membrane Market, 2021-2031($Million)
Figure 41. India Cell Line and Membrane Market, 2021-2031($Million)
Figure 42. South Korea Cell Line and Membrane Market, 2021-2031($Million)
Figure 43. Rest of Asia-Pacific Cell Line and Membrane Market, 2021-2031($Million)
Figure 44. Brazil Cell Line and Membrane Market, 2021-2031($Million)
Figure 45. Saudi Arabia Cell Line and Membrane Market, 2021-2031($Million)
Figure 46. South Africa Cell Line and Membrane Market, 2021-2031($Million)
Figure 47. Rest of LAMEA Cell Line and Membrane Market, 2021-2031($Million)
Figure 48. Top Winning Strategies, by Year
Figure 49. Top Winning Strategies, by Development
Figure 50. Top Winning Strategies, by Company
Figure 51. Product Mapping of Top 10 Players
Figure 52. Competitive Dashboard
Figure 53. Competitive Heatmap of Top 10 Key Players
Figure 54. Advanced Instruments LL.: Net Sales, ($Million)
Figure 55. Agc Biologic.: Net Sales, ($Million)
Figure 56. Cytiva Lifescience.: Net Sales, ($Million)
Figure 57. Sartoriu.: Net Sales, ($Million)
Figure 58. Cellgenix Gmb.: Net Sales, ($Million)
Figure 59. Premas Biotec.: Net Sales, ($Million)
Figure 60. Selexis S.: Net Sales, ($Million)
Figure 61. Samsung Biologic.: Net Sales, ($Million)
Figure 62. Lonz.: Net Sales, ($Million)
Figure 63. Thermofisher Scientific In.: Net Sales, ($Million)
Figure 64. Promocel.: Net Sales, ($Million)
Figure 65. Probioge.: Net Sales, ($Million)

Executive Summary

According to the report, “Cell Line and Membrane Market," the Cell Line and Membrane Market size was valued at $4.5 billion in 2021, and is estimated to reach $10.6 billion by 2031, growing at a CAGR of 8.8% from 2022 to 2031.

A cell line is a permanently established cell culture, which is frequently used to investigate biological processes in place of primary cells. Cell line is a general term that applies to a defined population of cells that can be maintained in culture for an extended period of time, retaining the stability of certain phenotypes and functions. It is used in a variety of applications, including the creation of biologics (recombinant proteins and monoclonal antibodies), drug screening, and gene functional investigations.

The key factors that drive the Cell Line and Membrane Market growth are rises in the prevalence of cancer and chronic diseases. Moreover, the rise in the geriatric population, an increase in the adoption of regenerative medicines, and a surge in investments in R&D by pharmaceutical and biotechnology companies propel the growth of the cell line and membrane market. Moreover, the market is expected to experience growth during the forecast period owing to a rise in development & demand for monoclonal antibodies around the globe, a surge in vaccine production, and technological innovations in cell lines & the membrane. For instance, in April 2020, CEVEC Pharmaceuticals GmbH announced the launch of the ELEVECTA platform that is expected to produce stable cell lines for AAV (Adeno-associated viral) vector for gene therapy.

However, a strict regulatory framework coupled with the time-consuming process for the development of stable lines might restrain the growth of the market. Whereas, low-income countries lack access to basic healthcare facilities, and the increase in the risk of pandemics and communicable diseases are some of the Cell Line and Membrane Market trends which further drives the growth of market .

The Cell Line Market is segmented on the basis of product, source, type, end user, and region. By product, the market is segmented into media & reagents, equipment, and accessories & consumables. By source, it is bifurcated into mammalian cell lines and non-mammalian cell lines. By type, the market is fragmented into recombinant cell type, hybridomas, continuous cell line, and primary cell line. By end user, the market is divided into biotech companies, academic & research institutes, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

On the basis of product, the Cell Membrane Market is segmented into media & reagents, equipment, and accessories & consumables. In 2021, the media and reagents segment accounted for the largest share of the market. The dominance of this segment can be attributed to the rise in prevalence of cancer & chronic diseases and rise in the number of R&D activities across the world, increasing product approval and new product launches.

On the basis of source, the cell line and membrane market is segmented into mammalian cell line and non-mammalian cell line. In 2021, the mammalian cell line segment accounted for the largest share of the market. The dominance of this segment can be attributed to the rise in the demand for recombinant protein development through the mammalian cell.

On the basis of type, the market is segmented into recombinant cell type, hybridomas, continuous cell line and primary cell line. The recombinant cell line segment exhibited the highest growth in 2021, and is anticipated to lead during the forecast period owing to the rise in demand for recombinant cell lines, which owes a great deal to technological advancement in expression vector design, cell line engineering, and clone screening.

By end user, the market is divided into biotech companies, academic and research institutes, and others. The biotechnology and pharmaceutical industries segment exhibited the highest growth in 2021 and is anticipated to lead during the forecast period, owing to the rise in the demand for biotherapeutic and biosimilar drugs. The increase in the geriatric population and the rise in the prevalence of cancer are the key factors that drive the growth of the market in the upcoming years.

North America accounted for a majority of the cell line and membrane market share in 2021 and is anticipated to remain dominant during the forecast period owing to rise in the prevalence of cancer, increased use of media & reagents for cell line development, and the presence of major key players.

Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to a rise in the prevalence of chronic diseases and an increase in the geriatric population in developing countries.

The key players that operate in the cell line and membrane market are Advanced Instruments LLC, AGC Biologics, Cytiva Lifesciences, Sartorius Cellgenix Gmbh, Premas Biotech, Selexis SA, Lonza, Samsung Biologics, PromoCell, Thermofisher Scientific Inc, Imegenex India Pvt. Ltd., and ProBioGen.

Key Findings of the Study

  • By product, the media and reagents segment were the highest contributor to the market in 2021
  • By source, the mammalian cell line segment was the highest contributor to the market in 2021.
  • By type, the recombinant cell line segment was the highest contributor in 2021.
  • By end user, the biotechnology and pharmaceutical industries dominated the market in 2021 and is expected to continue this trend during the forecast period.
  • By Region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • Advanced Instruments LLC
  • AGC Biologics
  • Cytiva Lifesciences
  • Sartorius
  • Cellgenix Gmbh
  • Premas Biotech
  • Selexis SA
  • Samsung Biologics
  • Lonza
  • Thermofisher Scientific Inc
  • PromoCell
  • ProBioGen

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...